Biological Planning of Radiation Dose Based on In Vivo Dosimetry for Postoperative Vaginal-Cuff HDR Interventional Radiotherapy (Brachytherapy)
(1) Background: Postoperative vaginal-cuff HDR interventional radiotherapy (brachytherapy) is a standard treatment in early-stage endometrial cancer. This study reports the effect of in vivo dosimetry-based biological planning for two different fractionation schedules on the treatment-related toxici...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/72b51afaad9743568ded63bddfb66880 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:72b51afaad9743568ded63bddfb66880 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:72b51afaad9743568ded63bddfb668802021-11-25T16:49:47ZBiological Planning of Radiation Dose Based on In Vivo Dosimetry for Postoperative Vaginal-Cuff HDR Interventional Radiotherapy (Brachytherapy)10.3390/biomedicines91116292227-9059https://doaj.org/article/72b51afaad9743568ded63bddfb668802021-11-01T00:00:00Zhttps://www.mdpi.com/2227-9059/9/11/1629https://doaj.org/toc/2227-9059(1) Background: Postoperative vaginal-cuff HDR interventional radiotherapy (brachytherapy) is a standard treatment in early-stage endometrial cancer. This study reports the effect of in vivo dosimetry-based biological planning for two different fractionation schedules on the treatment-related toxicities. (2) Methods: 121 patients were treated. Group A (82) received 21 Gy in three fractions. Group B (39) received 20 Gy in four fractions. The dose was prescribed at a 5 mm depth or to the applicator surface according to the distance between the applicator and the rectum. In vivo dosimetry measured the dose of the rectum and/or urinary bladder. With a high measured dose, the dose prescription was changed from a 5 mm depth to the applicator surface. (3) Results: The median age was 66 years with 58.8 months mean follow-up. The dose prescription was changed in 20.7% of group A and in 41% of group B. Most toxicities were grade 1–2. Acute urinary toxicities were significantly higher in group A. The rates of acute and late urinary toxicities were significantly higher with a mean bladder dose/fraction of >2.5 Gy and a total bladder dose of >7.5 Gy. One patient had a vaginal recurrence. (4) Conclusions: Both schedules have excellent local control and acceptable rates of toxicities. Using in vivo dosimetry-based biological planning yielded an acceptable dose to the bladder and rectum.Tamer SororRamin ChafiiValentina LancellottaLuca TagliaferriGyörgy KovácsMDPI AGarticleinterventional radiotherapyvaginal-cuff brachytherapyHDR brachytherapyin vivo dosimetryendometrial cancerbiological planningBiology (General)QH301-705.5ENBiomedicines, Vol 9, Iss 1629, p 1629 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
interventional radiotherapy vaginal-cuff brachytherapy HDR brachytherapy in vivo dosimetry endometrial cancer biological planning Biology (General) QH301-705.5 |
spellingShingle |
interventional radiotherapy vaginal-cuff brachytherapy HDR brachytherapy in vivo dosimetry endometrial cancer biological planning Biology (General) QH301-705.5 Tamer Soror Ramin Chafii Valentina Lancellotta Luca Tagliaferri György Kovács Biological Planning of Radiation Dose Based on In Vivo Dosimetry for Postoperative Vaginal-Cuff HDR Interventional Radiotherapy (Brachytherapy) |
description |
(1) Background: Postoperative vaginal-cuff HDR interventional radiotherapy (brachytherapy) is a standard treatment in early-stage endometrial cancer. This study reports the effect of in vivo dosimetry-based biological planning for two different fractionation schedules on the treatment-related toxicities. (2) Methods: 121 patients were treated. Group A (82) received 21 Gy in three fractions. Group B (39) received 20 Gy in four fractions. The dose was prescribed at a 5 mm depth or to the applicator surface according to the distance between the applicator and the rectum. In vivo dosimetry measured the dose of the rectum and/or urinary bladder. With a high measured dose, the dose prescription was changed from a 5 mm depth to the applicator surface. (3) Results: The median age was 66 years with 58.8 months mean follow-up. The dose prescription was changed in 20.7% of group A and in 41% of group B. Most toxicities were grade 1–2. Acute urinary toxicities were significantly higher in group A. The rates of acute and late urinary toxicities were significantly higher with a mean bladder dose/fraction of >2.5 Gy and a total bladder dose of >7.5 Gy. One patient had a vaginal recurrence. (4) Conclusions: Both schedules have excellent local control and acceptable rates of toxicities. Using in vivo dosimetry-based biological planning yielded an acceptable dose to the bladder and rectum. |
format |
article |
author |
Tamer Soror Ramin Chafii Valentina Lancellotta Luca Tagliaferri György Kovács |
author_facet |
Tamer Soror Ramin Chafii Valentina Lancellotta Luca Tagliaferri György Kovács |
author_sort |
Tamer Soror |
title |
Biological Planning of Radiation Dose Based on In Vivo Dosimetry for Postoperative Vaginal-Cuff HDR Interventional Radiotherapy (Brachytherapy) |
title_short |
Biological Planning of Radiation Dose Based on In Vivo Dosimetry for Postoperative Vaginal-Cuff HDR Interventional Radiotherapy (Brachytherapy) |
title_full |
Biological Planning of Radiation Dose Based on In Vivo Dosimetry for Postoperative Vaginal-Cuff HDR Interventional Radiotherapy (Brachytherapy) |
title_fullStr |
Biological Planning of Radiation Dose Based on In Vivo Dosimetry for Postoperative Vaginal-Cuff HDR Interventional Radiotherapy (Brachytherapy) |
title_full_unstemmed |
Biological Planning of Radiation Dose Based on In Vivo Dosimetry for Postoperative Vaginal-Cuff HDR Interventional Radiotherapy (Brachytherapy) |
title_sort |
biological planning of radiation dose based on in vivo dosimetry for postoperative vaginal-cuff hdr interventional radiotherapy (brachytherapy) |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/72b51afaad9743568ded63bddfb66880 |
work_keys_str_mv |
AT tamersoror biologicalplanningofradiationdosebasedoninvivodosimetryforpostoperativevaginalcuffhdrinterventionalradiotherapybrachytherapy AT raminchafii biologicalplanningofradiationdosebasedoninvivodosimetryforpostoperativevaginalcuffhdrinterventionalradiotherapybrachytherapy AT valentinalancellotta biologicalplanningofradiationdosebasedoninvivodosimetryforpostoperativevaginalcuffhdrinterventionalradiotherapybrachytherapy AT lucatagliaferri biologicalplanningofradiationdosebasedoninvivodosimetryforpostoperativevaginalcuffhdrinterventionalradiotherapybrachytherapy AT gyorgykovacs biologicalplanningofradiationdosebasedoninvivodosimetryforpostoperativevaginalcuffhdrinterventionalradiotherapybrachytherapy |
_version_ |
1718412903729594368 |